Electrome Provides Update on Veterans Health Activity

Electrome Corporation today provided an update on the company's activity with veteran serving health systems and clinical programs supporting non opioid pain care for veterans. Engagement is structured around the company's provider program lines and aligned with the existing stepped care infrastructure of the systems involved.

Update scope

Activity remains in deployment and operations phases inside aligned health systems. The company is not announcing system level endorsements, which is not how these systems operate, and is not a posture serious vendors pursue.

Forward looking statements

This release includes forward looking statements regarding deployment activity. Actual progress may differ.

About the program

The Electrome veteran initiative is a coordinated set of programs that supports the deployment of FDA cleared pulsed shortwave therapy for veterans through Department of Veterans Affairs facilities, Veteran Service Organizations, and adjacent community based partners. The initiative emphasizes the non opioid clinical profile of the underlying device, the wearable form factor that fits into routine veteran daily life, and the platform's ability to capture adherence and patient reported outcomes that align with the VA's quality measurement priorities.

Why the focus on veterans

Veterans carry a disproportionate burden of chronic musculoskeletal pain, and the VA has been one of the most consistent voices in federal healthcare on the need for credible non opioid options. The bioelectric category, anchored by the FDA cleared pulsed shortwave therapy device behind PAINKILLER, fits that need cleanly. Electrome's veteran programs are designed to support the VA's stated priorities while respecting the operational realities of how care is delivered inside the system.

About Electrome Corporation

Electrome Corporation operates the bioelectric medicine platform behind PAINKILLER and a portfolio of clinical, research, and commercial programs. The company's veteran initiative is one of several coordinated channels through which the FDA cleared device is reaching the patient populations that benefit most from a non opioid wearable bioelectric option.

About the launch program

The PAINKILLER launch program is structured to give patients real access through multiple credible channels. Direct to consumer access is supported through the PAINKILLER shop. Provider channel access is supported through programs designed for clinics that serve patients with chronic musculoskeletal pain. Retail availability is rolling out through partners selected for their existing pain category presence and their fit with the product positioning. The launch program is coordinated through the same Electrome platform that supports adherence, outcomes capture, and continued patient engagement after the purchase, so the patient experience is consistent regardless of the channel through which they entered.